A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma

This study is not yet open for participant recruitment.

Study NCT00551252 Information provided by Gruppo Italiano MEsotelioma

First Received: October 29, 2007 No Changes Posted

No Study Results Posted for this Study

Study Status:	This study is not yet open for participant recruitment.
Estimated Study Completion Date:	December 2009
Estimated Primary Completion Date:	No date given